Cargando…

PIK3CA Mutations in Hepatocellular Carcinoma in Korea

PURPOSE: Phosphatidylinositol 3-kinases/AKT pathway plays a pivotal role in hepatocellular carcinoma (HCC). Mutant PIK3CA, encoding the p110a catalytic subunit, stimulates the AKT pathway and promotes cell growth in various cancers. PIK3CA mutation rate has been usually reported as low frequency (&l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Heesue, Park, Cheol-Keun, Lee, Su Jin, Rha, Sun Young, Park, Kyu Hyun, Lim, Ho Yeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663228/ https://www.ncbi.nlm.nih.gov/pubmed/23709421 http://dx.doi.org/10.3349/ymj.2013.54.4.883

Ejemplares similares

Novel EGFR-TK Inhibitor EKB-569 Inhibits Hepatocellular Carcinoma Cell Proliferation by AKT and MAPK Pathways
por: Kim, Heesue, et al.
Publicado: (2011)

PIK3CA mutation detection in metastatic biliary cancer using cell-free DNA
por: Kim, Seung Tae, et al.
Publicado: (2015)

PIK3CA Mutation Is Associated with Poor Response to HER2-Targeted Therapy in Breast Cancer Patients
por: Kim, Ju Won, et al.
Publicado: (2023)

Prognostic implications of PIK3CA amplification in curatively resected liposarcoma
por: Kim, Joo Hoon, et al.
Publicado: (2016)

Mutation of the PIK3CA oncogene in human cancers
por: Karakas, B, et al.
Publicado: (2006)

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma
por: Deshpande, Vikram, et al.
Publicado: (2011)

Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy
por: Kim, Seung Tae, et al.
Publicado: (2017)

Pilot study of sirolimus in patients with PIK3CA mutant/amplified refractory solid cancer
por: Jung, Ki Sun, et al.
Publicado: (2017)

Mutations in TP53 and PIK3CA genes in hepatocellular carcinoma patients are associated with chronic Schistosomiasis
por: AlGabbani, Qwait
Publicado: (2022)

PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer
por: Kim, Ji-Won, et al.
Publicado: (2017)

Oncogenic PIK3CA Mutation and Dysregulation in Human Salivary Duct Carcinoma
por: Qiu, Wanglong, et al.
Publicado: (2014)

Trends and Patterns of Hepatocellular Carcinoma Treatment in Korea
por: Hong, Young Mi, et al.
Publicado: (2016)

BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy
por: Colombino, M, et al.
Publicado: (2012)

Mutations of PIK3CA in gastric adenocarcinoma
por: Li, Vivian Sze Wing, et al.
Publicado: (2005)

Mutations in PIK3CA are infrequent in neuroblastoma
por: Dam, Vincent, et al.
Publicado: (2006)

PIK3CA-mutations in breast cancer
por: Reinhardt, Kristin, et al.
Publicado: (2022)

Clinicopathological Characteristics of PIK3CA Mutation and Amplification in Korean Patients with Breast Cancers
por: Lee, Moo-Hyun, et al.
Publicado: (2020)

PIK3CA Mutation as Potential Poor Prognostic Marker in Asian Female Breast Cancer Patients Who Received Adjuvant Chemotherapy
por: Cho, Yoon Ah, et al.
Publicado: (2022)

PIK3CA gene mutations in Northwest Chinese esophageal squamous cell carcinoma
por: Liu, Shi-Yuan, et al.
Publicado: (2017)

The Impact of Cetuximab Plus AKT- or mTOR- Inhibitor in a Patient-Derived Colon Cancer Cell Model with Wild-Type RAS and PIK3CA Mutation
por: Kim, Ju Sun, et al.
Publicado: (2017)

PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival
por: Rosty, Christophe, et al.
Publicado: (2013)

Activation of diverse signaling pathways by oncogenic PIK3CA mutations
por: Wu, Xinyan, et al.
Publicado: (2014)

Initiating breast cancer by PIK3CA mutation
por: Miller, Todd W
Publicado: (2012)

PIK3CA Mutational Analysis of Parathyroid Adenomas
por: Riccardi, Aaliyah, et al.
Publicado: (2020)

Detailed analysis of phenotypes and genotypes in megalencephaly-capillary malformation-polymicrogyria syndrome caused by somatic mosaicism of PIK3CA mutations
por: Park, Hyun Jin, et al.
Publicado: (2020)

Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo
por: Cocco, Emiliano, et al.
Publicado: (2016)

Unilateral synchronous papillary renal neoplasm with reverse polarity and clear cell renal cell carcinoma: a case report with KRAS and PIK3CA mutations
por: Lee, Hyun Jung, et al.
Publicado: (2020)

PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression
por: Shah, Vandna, et al.
Publicado: (2017)

Biology and Targetability of the Extended Spectrum of PIK3CA Mutations Detected in Breast Carcinoma
por: Rugo, Hope S., et al.
Publicado: (2023)

Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
por: Chen, Li, et al.
Publicado: (2018)

Analysis of PIK3CA Mutation Concordance and Frequency in Primary and Different Distant Metastatic Sites in Breast Cancer
por: Park, Jieun, et al.
Publicado: (2023)

Activation of WNT/β‐catenin signaling results in resistance to a dual PI3K/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations
por: Park, Ye‐Lim, et al.
Publicado: (2018)

Clinical implications of genomic profiles in metastatic breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated genes
por: Kim, Ji-Yeon, et al.
Publicado: (2017)

EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas
por: BUJKO, MATEUSZ, et al.
Publicado: (2014)

PIK3CA Mutations in Advanced Cancers: Characteristics and Outcomes
por: Janku, Filip, et al.
Publicado: (2012)

Cancer-Associated PIK3CA Mutations in Overgrowth Disorders
por: Madsen, Ralitsa R., et al.
Publicado: (2018)

PIK3CA mutation and colorectal cancer precision medicine
por: Hamada, Tsuyoshi, et al.
Publicado: (2017)

Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
por: Hutchinson, Katherine E., et al.
Publicado: (2023)

Carcinogenesis of PIK3CA
por: German, Sidra, et al.
Publicado: (2013)

Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma
por: Murakami, Kosuke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r203qdugph2tf2eni8dbprpjuc